ImpediMed Limited
IPDQF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $111,773 | $116,313 | $195 | $235 |
| - Cash | $22 | $18 | $25 | $37 |
| + Debt | $14 | $1 | $1 | $1 |
| Enterprise Value | $111,765 | $116,297 | $172 | $199 |
| Revenue | – | $6 | $6 | $5 |
| % Growth | – | 8.5% | 15.7% | – |
| Gross Profit | – | $5 | $5 | -$8 |
| % Margin | – | 88.1% | 87.7% | -163.6% |
| EBITDA | – | -$9 | -$11 | -$5 |
| % Margin | – | -156% | -195.7% | -110.7% |
| Net Income | – | -$11 | -$10 | -$10 |
| % Margin | – | -185.5% | -182% | -203.1% |
| EPS Diluted | – | 0 | -0.005 | -0.005 |
| % Growth | – | 100% | 0% | – |
| Operating Cash Flow | – | -$7 | -$11 | -$7 |
| Capital Expenditures | – | $0 | -$3 | -$2 |
| Free Cash Flow | – | -$7 | -$14 | -$8 |